| Ytd | 19.53% | |
| 1y | -10.21% |
| Open | 97.64 | Prev Close | 98.65 | Low | 94.45 | High | 99.07 | Mkt Cap | 4.51B |
| Vol | 233.91K | Avg Vol | 787.24K | EPS | 0.70 | P/E | 140.09 | Forward P/E | 70.22 |
| Beta | N/A | Short Ratio | 3.19 | Inst. Own | 35.62% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 115.95 | 200-d Avg | 95.40 | 1yr Est | 121.43 |
Billiontoone, Inc. (NASDAQ: BLLN - Get Free Report) has been given a consensus rating of "Moderate B
BillionToOne experienced a sharp post-earnings sell-off despite maintaining full-year guidance and s
Gainers Creative Medical Tech (NASDAQ:CELZ) stock increased by 107.8% to $1.39 during Thursday'
Gainers Creative Medical Tech (NASDAQ:CELZ) stock increased by 86.9% to $1.25 during Thursday's
While the top- and bottom-line numbers for BillionToOne (BLLN) give a sense of how the business perf
Billiontoone NASDAQ: BLLN reported second-quarter 2026 revenue growth of 64% year over year, driven
Gainers Creative Medical Tech (NASDAQ:CELZ) stock moved upwards by 31.4% to $0.88 during Wednesday&
MENLO PARK, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-gene
Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the natio
MENLO PARK, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-gene
According to a Form 4 filing, a BillionToOne executive sold 801 shares of Class A Common Stock at $1
Tom Gardner makes the case for fifty-stock portfolios and AI-powered research, then names five compa
Here is how BillionToOne (BLLN) and Concentra Group (CON) have performed compared to their sector so
BillionToOne's Northstar Response Is a Stronger Predictor of Immunotherapy Outcomes Than Standard-o
Tissue-free ctDNA monitoring was the dominant independent predictor of survival across 12 tumor type
Here is how BillionToOne (BLLN) and Eledon Pharmaceuticals, Inc. (ELDN) have performed compared to t
MENLO PARK, Calif., May 27, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-gener
During the quarter, we added 9 new positions and exited 11 positions, bringing the number of positio
The average of price targets set by Wall Street analysts indicates a potential upside of 37% in Bill
The mean of analysts' price targets for BillionToOne (BLLN) points to a 25.6% upside in the stock. W
Although the revenue and EPS for BillionToOne (BLLN) give a sense of how its business performed in t
MENLO PARK, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-gener
A breakthrough in prenatal care, Unity Confirm enables non-invasive confirmation for high-risk scree
Cramer shared his thoughts on various stocks, calling Joby Aviation too risky, BillionToOne a winner
Summary:Top Wall Street analysts changed outlook on top names. Analyst ratings page shows all chang